Risankizumab for the treatment of genital psoriasis: A 1-year, real-world experience

J Eur Acad Dermatol Venereol. 2024 Mar;38(3):e256-e258. doi: 10.1111/jdv.19562. Epub 2023 Oct 17.

D Orsini¹, P Frascione², C Assorgi³, A Pacifico¹, I Sperduti⁴, L Gargiulo^{5

6}, L Ibba^{5

6}, M Valenti^{5

6}, A Costanzo^{4

5}, A Narcisi⁵

¹ Clinical Dermatology Unit, San Gallicano Dermatological Institute IRCCS, Rome, Italy.
² Dermatology Oncology Unit, San Gallicano Dermatological Institute IRCCS, Rome, Italy.
³ Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
⁴ Biostatistical Unit, IRCCS 'Regina Elena' National Cancer Institute, Rome, Italy.
⁵ Dermatology Unit, IRCCS Humanitas Research Hospital, Rozzano (MI), Italy.
⁶ Department of Biomedical Sciences, Humanitas University, Italy.

No abstract available

Publication types